Literature DB >> 18329616

Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport.

Seiya Yamayoshi1, Takeshi Noda, Hideki Ebihara, Hideo Goto, Yuko Morikawa, Igor S Lukashevich, Gabriele Neumann, Heinz Feldmann, Yoshihiro Kawaoka.   

Abstract

The Ebola virus matrix protein VP40 plays an important role in virion formation and viral egress from cells. However, the host cell proteins and mechanisms responsible for intracellular transport of VP40 prior to its contribution to virion formation remain to be elucidated. Therefore we used coimmunoprecipitation and mass spectrometric analyses to identify host proteins interacting with VP40. We found that Sec24C, a component of the host COPII vesicular transport system, interacts specifically with VP40 via VP40 amino acids 303 to 307. Coimmunoprecipitation and dominant-negative mutant studies indicated that the COPII transport system plays a critical role in VP40 intracellular transport to the plasma membrane. Marburg virus VP40 was also shown to use the COPII transport system for intracellular transport. These findings identify a conserved intersection between a host pathway and filovirus replication, an intersection that can be targeted in the development of new antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329616      PMCID: PMC2330329          DOI: 10.1016/j.chom.2008.02.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  39 in total

Review 1.  Filovirus assembly and budding.

Authors:  Bettina Hartlieb; Winfried Weissenhorn
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

Review 2.  ER-to-Golgi transport: form and formation of vesicular and tubular carriers.

Authors:  Peter Watson; David J Stephens
Journal:  Biochim Biophys Acta       Date:  2005-03-23

Review 3.  COPI-mediated transport.

Authors:  J Béthune; F Wieland; J Moelleken
Journal:  J Membr Biol       Date:  2006-10-14       Impact factor: 1.843

4.  COPII-cargo interactions direct protein sorting into ER-derived transport vesicles.

Authors:  M J Kuehn; J M Herrmann; R Schekman
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

5.  Ebola virus VP40 late domains are not essential for viral replication in cell culture.

Authors:  Gabriele Neumann; Hideki Ebihara; Ayato Takada; Takeshi Noda; Darwyn Kobasa; Luke D Jasenosky; Shinji Watanabe; Jin H Kim; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Coupling of ER exit to microtubules through direct interaction of COPII with dynactin.

Authors:  Peter Watson; Rebecca Forster; Krysten J Palmer; Rainer Pepperkok; David J Stephens
Journal:  Nat Cell Biol       Date:  2004-12-05       Impact factor: 28.824

7.  Sec24 proteins and sorting at the endoplasmic reticulum.

Authors:  A Pagano; F Letourneur; D Garcia-Estefania; J L Carpentier; L Orci; J P Paccaud
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

8.  ER-to-Golgi transport visualized in living cells.

Authors:  J F Presley; N B Cole; T A Schroer; K Hirschberg; K J Zaal; J Lippincott-Schwartz
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

9.  Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.

Authors:  E Mühlberger; M Weik; V E Volchkov; H D Klenk; S Becker
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.

Authors:  Shinji Watanabe; Takeshi Noda; Peter Halfmann; Luke Jasenosky; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

View more
  48 in total

1.  Unconventional secretion of Ebola virus matrix protein VP40.

Authors:  Olivier Reynard; St Patrick Reid; Audrey Page; Mathieu Mateo; Nathalie Alazard-Dany; Hervé Raoul; Christopher F Basler; Viktor E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

3.  Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.

Authors:  Kevin B Spurgers; Tim Alefantis; Brian D Peyser; Gordon T Ruthel; Alison A Bergeron; Julie A Costantino; Sven Enterlein; Krishna P Kota; R C Dutch Boltz; M Javad Aman; Vito G Delvecchio; Sina Bavari
Journal:  Mol Cell Proteomics       Date:  2010-08-11       Impact factor: 5.911

4.  Role of Coatomer Protein I in Virus Replication.

Authors:  Jennifer A Thompson; Jay C Brown
Journal:  J Virol Antivir Res       Date:  2012-10-30

5.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

Review 6.  Proteomics Tracing the Footsteps of Infectious Disease.

Authors:  Todd M Greco; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2017-02-05       Impact factor: 5.911

Review 7.  Elucidation of host-pathogen protein-protein interactions to uncover mechanisms of host cell rewiring.

Authors:  Charlotte Nicod; Amir Banaei-Esfahani; Ben C Collins
Journal:  Curr Opin Microbiol       Date:  2017-08-11       Impact factor: 7.934

8.  The Impact of Mass Spectrometry-Based Proteomics on Fundamental Discoveries in Virology.

Authors:  Todd M Greco; Benjamin A Diner; Ileana M Cristea
Journal:  Annu Rev Virol       Date:  2014-07-14       Impact factor: 10.431

9.  Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.

Authors:  Seiya Yamayoshi; Mariko Watanabe; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

10.  Marburg virus evades interferon responses by a mechanism distinct from ebola virus.

Authors:  Charalampos Valmas; Melanie N Grosch; Michael Schümann; Judith Olejnik; Osvaldo Martinez; Sonja M Best; Verena Krähling; Christopher F Basler; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.